Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
Argentina: GEP filed new opposition to patent request for Hepatitis C drugNews
A significant step in ensuring access to treatment for the 800,000 people living with hepatitis C in Argentina. Earlier this...
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/rNews
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine. On 30 January...
Brazilian National Institute of Industrial Property Rejects Truvada® Patent ApplicationNews
On 24 January 2017, Brazil’s National Institute of Industrial Property (INPI) made public a decision to reject the patent application...
Patent on HIV and Hepatitis drug TAF challenged in UkraineNews
On 28 December 2016, the All-Ukrainian Network of People Living with HIV/AIDS submitted a patent invalidation claim against Gilead patent...
Debating patent law and access to medicines in UkraineNews
Last month (9 December 2016), the All-Ukrainian Network of People Living with HIV/AIDS held a roundtable meeting on ‘Patent Law...
Open Letter to WHO Director General, Margaret ChanNews
Civil Society Open Letter urging WHO to include UN High Level Panel on Access to Medicines Report on WHO Board Agenda
Thai Activists and Hospital Staff Review Progress on HCV TreatmentNews
Community groups and government hospital staff from eight provinces met to review access to medicines on 15 and 16 November. The...
Access to Medicines, Medical Technologies and Human Rights MeetingNews
15 years of the Doha Declaration on TRIPS and Public Health: The meeting will examine health safeguards as effective tools...
Kyrgyzstan’s new patent law results in affordable life-saving drugsNews
In April 2015 Kyrgyzstan’s president took the necessary step of signing in a new patent law. This was the result...
Pressure leads to incorporation of new antiretroviralNews
The incorporation of a new antiretroviral in Brazil’s national treatment guidelines, and the scale up of a second-line treatment are...